X0306 4 2021-04-16 0 0001087294 CUMBERLAND PHARMACEUTICALS INC CPIX 0001075050 KAZIMI A J 2525 WEST END AVE. SUITE 950 NASHVILLE TN 37203 1 1 1 0 Chairman and CEO Common Stock 2021-04-16 4 P 0 15 3.03 A 5767734 D Common Stock 2021-04-19 4 P 0 15 3.04 A 5767749 D Common Stock 2021-04-20 4 P 0 15 3.02 A 5767764 D Common Stock 2021-04-21 4 P 0 15 2.97 A 5767779 D Common Stock 2021-04-22 4 P 0 15 2.96 A 5767794 D Common Stock 2021-04-23 4 P 0 15 2.99 A 5767809 D Common Stock 2021-04-26 4 P 0 15 2.97 A 5767824 D Common Stock 2021-04-27 4 P 0 15 2.94 A 5767839 D Common Stock 2021-04-28 4 P 0 15 2.94 A 5767854 D Common Stock 2021-04-29 4 P 0 15 2.89 A 5767869 D Common Stock 2021-04-30 4 P 0 15 2.78 A 5767884 D Common Stock 2021-05-03 4 P 0 15 2.66 A 5767899 D Common Stock 2021-05-04 4 P 0 15 2.66 A 5767914 D Common Stock 2021-05-05 4 P 0 15 2.73 A 5767929 D Common Stock 2021-05-06 4 P 0 15 2.74 A 5767944 D Common Stock 2021-05-07 4 P 0 15 2.73 A 5767959 D Common Stock 2021-05-10 4 P 0 15 2.71 A 5767974 D Common Stock 2021-05-11 4 P 0 15 2.68 A 5767989 D Common Stock 2021-05-12 4 P 0 15 2.86 A 5768004 D Common Stock 2021-05-13 4 P 0 15 2.88 A 5768019 D Common Stock 2021-05-14 4 P 0 15 2.81 A 5768034 D Common Stock 2021-05-17 4 P 0 15 2.84 A 5768049 D Common Stock 2021-05-18 4 P 0 15 2.89 A 5768064 D Common Stock 2021-05-19 4 P 0 15 2.83 A 5768079 D Common Stock 2021-05-20 4 P 0 15 2.94 A 5768094 D Common Stock 2021-05-21 4 P 0 15 3.06 A 5768109 D Common Stock 2021-05-24 4 P 0 15 3.05 A 5768124 D Common Stock 2021-05-25 4 P 0 15 2.91 A 5768139 D Common Stock 2021-05-26 4 P 0 15 2.85 A 5768154 D Common Stock 2021-05-27 4 P 0 15 2.94 A 5768169 D The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. A.J. Kazimi by /s/ John Hamm as attorney-in-fact 2021-09-10